The trajectory of companies tied to flagship drugs like Viagra presents a complex investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key territories has introduced substantial risk . Investors are now assessing the effect of rival medications , diminis